Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human placental-derived stem cells
- Development stage
- Unknown
- Lead developer
- Celularity
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Human placental-derived stem cells are an investigational, allogeneic placental cell therapy prepared from donated full-term human placentas through a proprietary perfusion and cell-processing procedure. The product contains hematopoietic and non-hematopoietic stem and progenitor-cell populations, is low in T-cell content, and has relatively low HLA class I and class II expression. It has been administered as an HLA-independent facilitator cell product alongside allogeneic umbilical cord blood transplantation, with the intended biological role of supporting hematopoietic engraftment and immune reconstitution after transplant. New York Medical College conducted the completed Phase 1 NCT01586455 study in malignant hematologic disorders and inherited non-malignant conditions requiring stem-cell transplantation. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01586455))
- Other names
- HPDSCHPDSCshuman placenta derived stem cellshuman placenta-derived stem cellshuman placental derived stem cells
Beyond the preview
Go deeper on human placental-derived stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human placental-derived stem cells.